Received 12 September 1989/Accepted 20 November 1989 The binding and elution of spleen cells from plastic dishes coated with monophosphoryl lipid A (MPL) resulted in a >1,000-fold enrichment of antigen-specific suppressor T-cell (Ts) activity when spleen cells from mice 18 to 24 h after exposure to a low dose of type III pneumococcal polysaccharide (SSS-III) were used. The removal of MPL-adherent Ts cells resulted in an increase in the degree of amplifier T-cell (TA) activity present in the remaining MPL-nonadherent cell fraction; however, both Ts and TA activities were found in the MPL-adherent cell fraction when spleen cells from mice 4 days after immunization with an optimal dose of SSS-III were examined. These findings, as well as others, suggest that both Ts and TA, once activated, acquire a cell surface receptor that enables them to bind to MPL. Because of differences in the kinetics for the activation of Ts and TA during the course of the antibody response and the fact that Ts, but not TA, activity appears as early as 18 to 24 h after exposure to SSS-III, it is possible to use this experimental approach to obtain cell suspensions greatly enriched in Ts activity.
The magnitude of the antibody response to type III pneumococcal polysaccharide (SSS-III) is influenced in both a positive and a negative manner by the activities of two types of T cells having opposing functions; such regulatory T cells have been termed suppressor T cells (Ts) and amplifier T cells (TA), respectively (reviewed in references 1 and 6).
Ts limit the extent to which antigen-stimulated B cells proliferate, whereas TA drive B cells to proliferate further in response to antigen (1, 6, 11, 21) . Neither Ts nor TA are activated directly by antigen per se; rather, both are activated during the course of a normal antibody response by cell-associated antibody on the surface of immune B cells (14, 26) . Since the inhibitory effects produced by activated T. are antigen specific (12), the idiotypic determinants of cell-associated antibody most likely play a major role in this homeostatic control mechanism (1, 6, 14, 26) . Ts and TA differ with respect to the phenotype of the cell surface Lyt antigens they possess. Since they are T cells, both are Thy-1+; however, Ts are Lyt-1-, L3T4-, and Lyt-2+, whereas TA are Lyt-1+, L3T4+, and Lyt-2- (3, 4, 14, 22, 24, 25) . These differences have enabled one, by means of cell depletion procedures with appropriate monoclonal antibodies and complement, to demonstrate the activity of one type of regulatory T cell in the absence of the other in cell transfer experiments (3, 4, 24, 26 Coating culture dishes with MPL. Primaria culture dishes were flooded with 10 ml of 15% isopropyl alcohol and held at room temperature for 30 min. The alcohol was decanted and, while the dishes were still wet, 10 ml of a solution of MPL (10 p,g of MPL per ml in 0.05 M bicarbonate buffer, pH 9.5) was added. The dishes were incubated for 2 h at 37°C and then placed at 4°C overnight (12 to 18 h), after which the MPL was decanted and each dish was washed twice with 10 ml of bicarbonate buffer. About 10 ml of 0.01 M Tris buffer, pH 7.5, containing 0.2% bovine serum albumin and 0.1% Tween 20, was added, and the dishes were incubated for 1 h at 37°C; the solution was decanted from the dishes just prior to use.
The binding of MPL to the surface of coated dishes was affirmed by means of an enzyme-linked immunosorbent assay spot test. Discrete drops (10 [ul) containing twofold dilutions of a mouse monoclonal IgG2b antibody specific for lipid A (MoAb-H3) were applied in a linear pattern to the surface of a dish coated previously with MPL. The dish was held at room temperature for 1 h, after which it was rinsed with several volumes of phosphate-buffered saline to remove unbound antibody. Then, the dish was flooded with a dilute solution of affinity-purified goat anti-mouse IgG2b antibody to which was conjugated alkaline phosphatase; the dish was held at room temperature for 1 h, washed several times with phosphate-buffered saline, and then covered with 5 ml of melted (45°C) 0.6% agarose containing appropriate substrate. After incubation for about 1 h at 37°C, colored spots appeared only where monoclonal antibody specific for lipid A was applied. The application of monoclonal antibody not specific for lipid A was without effect. Although details concerning the preparation and specificity of monoclonal antibody MoAb-H3 have not been published, they can be obtained from J. T. Ulrich upon request.
Isolation of MPL-adherent cells. Spleen cell suspensions from mice given (i.p.) either a low (0.005 ,ug) or an optimally immunogenic (0.5 ,ug) dose of SSS-III were prepared in medium 199. The cells were washed once by centrifugation and adjusted to contain 107 nucleated cells per ml of medium 199. Then, 10 ml of the resulting cell suspension was added to each of 10 dishes coated previously with affinity-purified goat anti-mouse IgM antibody. The dishes were held at 4°C for 40 min, after which the cell suspension was swirled gently and the dishes were held at 4°C for 30 min. The contents were swirled once more, and the suspension of unbound B-cell-depleted cells (26) from one dish was added directly to a second dish coated previously with MPL. Those dishes were held at 4°C for 40 min and then, after swirling the contents, for 30 min at 4°C, after which the unbound cells were decanted and the dishes were rinsed twice with about 10 ml of medium 199 to remove residual unbound cells.
MPL-adherent cells were detached from each dish by the addition of S ml of a thymus cell extract containing 15 ,ug of soluble protein per ml of medium 199. After incubation for 10 min at 37°C, the detached cells were collected, washed once with medium 199, and suspended in a total volume of 2 ml of medium 199. The thymus cell extract, which we assume contains the full array of surface antigens present on all T cells including Ts, was prepared by disrupting a single cell suspension of thymus cells with a Teflon tissue homogenizer. The resulting suspension, which was initially prepared in phosphate-buffered saline, pH 7.4, was centrifuged to remove all insoluble material and then adjusted spectrophotometrically (optical density at 280 nm) to contain 1 mg of soluble protein per ml; this stock solution was stored in small aliquots at -70°C and diluted in medium 199 just before use.
In the experiments described, 39.0 + 3.7% (mean + standard error) of cells initially added did not attach to dishes coated with anti-mouse IgM antibody. About 52.8% of such cells, or about 20.6% of the initial spleen cell suspension, bind to MPL-coated dishes. Of the cells binding to MPL-coated dishes, about 15.7% are detached by the addition of thymus cell extract. Thus, the detached cells represent about 2.9% or less of the initial cell suspension. Ten dishes coated with anti-mouse IgM antibody and MPL provide enough donor cells for use in each of the experiments described.
We wish to emphasize the fact that different types of cells may bind to dishes coated with MPL; however, the present work deals with the functional activity of only those adherent cells that are detached after the addition of thymus cell extract. Although this results in a substantial enrichment of regulatory T-cell activity, we are not proposing that MPL binds specifically to such cells.
Monoclonal antibodies and their use. A 50-,ul portion of dilute (1:10) monoclonal anti-mouse Thy-1.2, Lyt-1.2, or Lyt-2.2 antibody (NEI-011, NEI-017, or NEI-006, respectively; Dupont NEN Research Products, Boston, Mass.) was added to 2.5 ml of washed MPL-adherent cells (about 5 x 106 to 10 x 106 cells per ml) in medium 199. The mixture was held at 4°C for 30 min, after which the cells were washed by centrifugation and suspended to the original volumes. Then, 1. 
RESULTS
Binding of Ts to MPL-coated dishes. A pooled spleen cell suspension was prepared from 10 mice 18 to 24 h after pretreatment (priming) with a single injection (i.p.) of a subimmunogenic (0.005 ,ug) dose of SSS-III to induce lowdose immunological paralysis, a form of unresponsiveness known to be mediated by Ts (3, 10, 11, 14) . Groups of mice were given (i.v.) 2 x 106 or 2 x 107 cells from this initial suspension, whereas other groups of mice were given (i.v.) The magnitude of the SSS-III-specific PFC response was decreased significantly (P < 0.05) in mice given 2 x 107, but not 2 x 106, cells from the initial suspension of primed spleen cells (Table 1 The administration of S x 105 MPL-adherent primed spleen cells caused significant (P < 0.01) suppression of the SSS-III-specific PFC response (Table 3) ; however, the PFC response to dextran was not suppressed (P > 0.05) in mice given the same cells. Thus, the suppression mediated by MPL-adherent (reviewed in reference 4). Therefore, if all or most of the activity of Ts is removed from a cell suspension as a result of binding to MPL-coated dishes, the remaining MPL-nonadherent cell fraction should be greatly enriched for TA activity. This possibility was examined in the following way. A pooled spleen cell suspension was prepared from 10 mice 4 days after immunization with 0.5 ,ug of SSS-III. Groups of mice were given (i.v.) various numbers of cells from either this initial cell suspension or the MPL-nonadherent cell suspension 2 days after recipient mice were immunized (i.p.) with 0.5 ,ug of SSS-III; previous studies showed that donor cells should be given 2 days after immunization with SSS-Ill to reveal isolated TA activity best (4, 14, 26) . The magnitude of the antibody (PFC) response produced was determined 5 days after immunization and compared with that of immunized mice not given donor cells.
The administration of 2 x 107 spleen cells from the initial cell suspension resulted in no significant change (Table 4 ; P > 0.05) in the magnitude of the PFC response; the transfer of smaller (2 x 106) or larger (8 x 107) numbers of cells likewise was without effect (P > 0.05; data not shown). Although the transfer of 2 x 106 MPL-nonadherent cells failed to influence the PFC response (P > 0.05), the administration of 4 x 106 and 8 x 106 MPL-nonadherent cells resulted in significant enhancement (P < 0.001, in both cases). Although these findings suggest that the binding of Ts to MPL can result in the enrichment of TA activity in the remaining nonadherent cell fraction, the results of another experiment (Table 5) show that both Ts and TA, which are activated and present in the spleen 4 days after immunization with an optimal dose of SSS-III (reviewed in reference 4), bind to MPL-coated dishes. Here, because of the competitive interaction between T. and TA, the administration of MPL-adherent donor cells treated with complement alone results in no significant change (P > 0.05) in the magnitude of the antibody response to SSS-III. Likewise, the inactivation of both types of regulatory T cells by treatment with monoclonal anti-Thy-1.1 plus complement is without effect (P > 0.05); however, treatment with monoclonal anti-Lyt-1 antibody plus complement (to remove TA activity) resulted in the expression of significant (P < 0.005) suppression, whereas treatment with monoclonal anti-Lyt-2 antibody plus complement (to remove Ts activity) led to the expression of significant (P < 0.05) enhancement. Since TA activity is not demonstrable in suspensions of MPL-adherent cells collected 18 to 24 h after exposure to SSS-III (Tables 1 and 2 ), it would appear that role. In the present work, the binding and subsequent elution of B-cell-depleted primed spleen cells from MPL-coated dishes result in more than a 100-to 1,000-fold enrichment of or nonadherent cell fraction is likely to depend on a number of variables such as (i) the number and proportion of activated Ts and TA present initially, (ii) differences between activated Ts and TA in the density or affinity of receptors for MPL, and (iii) differences between Ts and TA in the kinetics for their activation following exposure to antigen. With respect to the last possibility, there is evidence to indicate that Ts are activated as early as 18 to 24 h after exposure to SSS-III, whereas TA activity is not demonstrable before 2 to 3 days after exposure to SSS-III and maximal levels are not attained until 4 to 5 days after immunization (reviewed in reference 4). Therefore, by using spleen cells obtained 18 to 24 h after priming with SSS-111, one can obtain a substantial (>1,000-fold) enrichment of Ts activity in the MPL-adherent cell fraction. There is no procedure extant which will enable one to accomplish this objective.
The existence of a major bacterial LPS-binding protein (80 kilodaltons; 6.5 pI) on purified splenic B and T cells, as well as on macrophages, has been described before (19) . This LPS-binding protein reacts with the lipid A, but not the polysaccharide, portion of the LPS molecular complex (20).
It not only appears to be the dominant LPS-binding site on cells but also is present on the splenocytes of both LPSresponsive and LPS-unresponsive strains of C3H mice. In addition to this dominant LPS-binding site, two minor LPSbinding proteins (30 kilodaltons; pI > 6.5) can be detected only on T cells (19) ; it is not known whether these binding proteins are present on T cells of both LPS-responsive and LPS-unresponsive strains of C3H mice and whether they correspond to the MPL-binding site described in the present work. Other studies showed that LPS-responsive and LPSunresponsive strains of C3H mice do not differ in the degree of low-dose immunological paralysis induced and expressed upon exposure to SSS-III (17) . Since this form of unresponsiveness is mediated by Ts (3, 5) , these strains of mice do not differ with respect to Ts function; however, low-dose paralysis is abrogated only in LPS-responsive C3H mice treated with MPL (17) . This suggests that, if there indeed is an MPL-specific binding site on Ts, it functions in LPS-responsive, but not LPS-unresponsive, strains of C3H mice. Alternatively, MPL may bind equally to Ts of both strains of mice; however, MPL may decrease the functional activity of Ts present in only LPS-responsive C3H mice. These possibilities are being examined.
